Why RNA? Atrium Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
RNA
$12.87-0.56 (-4.17%)
After Hours$12.87+0.00 (+0.00%)· Last close May 4
Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies.